DSM Obtains Exclusive World-Wide License for Innovative Drug Delivery Technology
Royal DSM N.V., the global Life Sciences and Materials Sciences company headquartered in the Netherlands, today announces that DSM Biomedical obtained an exclusive world-wide license for a unique drug & biologic delivery system developed by MediVas LLC, a San Diego based biomedical company. Integrated into DSM’s Trancerta(R) Drug Delivery platform, this will open up a broad range of opportunities for next generation drug delivery.